"Does AbbVie have a role in consolidation in the industry if this combination doesn't happen? The answer is yes. Does Shire have a role to play? Yes," David Amsellem, a New York-based analyst at Piper Jaffray Cos., said in a phone interview. "Shire will have a lot of options irrespective of AbbVie."